Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

WENQING ZHANG

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1720286594
CMS profile
259562
Location
INVERNESS, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$5,219.55

188 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $4,343.03 179
Long term medical supply or device loan $681.53 7
Education $194.99 2

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Novartis Pharmaceuticals Corporation $936.30 23
Incyte Corporation $437.85 13
E.R. Squibb & Sons, L.L.C. $357.04 14
AstraZeneca Pharmaceuticals LP $290.33 8
Merck Sharp & Dohme LLC $227.36 10
Gilead Sciences, Inc. $218.74 6
PFIZER INC. $203.69 9
Janssen Biotech, Inc. $200.16 6
Eisai Inc. $171.28 9
PUMA BIOTECHNOLOGY, INC. $161.36 3
Celgene Corporation $155.14 9
GlaxoSmithKline, LLC. $120.92 5
Bayer Healthcare Pharmaceuticals Inc. $114.51 5
Daiichi Sankyo Inc. $103.04 5
SEAGEN INC. $99.99 1
ABBVIE INC. $97.01 5
ARRAY BIOPHARMA INC $85.79 4
Takeda Pharmaceuticals U.S.A., Inc. $84.09 3
Lilly USA, LLC $76.65 3
SUN PHARMACEUTICAL INDUSTRIES INC. $69.68 2
Regeneron Healthcare Solutions, Inc. $68.55 3
SOBI, INC $65.59 2
Novocure Inc. $58.71 2
Stemline Therapeutics Inc. $57.94 3
BeiGene USA, Inc. $56.88 2
GENZYME CORPORATION $56.22 2
PharmaEssentia USA Corporation $52.27 2
Alexion Pharmaceuticals, Inc. $48.84 3
BeOne Medicines USA, Inc. $47.76 2
EMD Serono, Inc. $42.28 2
RECORDATI_RARE_DISEASES_INC. $42.26 2
Boehringer Ingelheim Pharmaceuticals, Inc. $41.04 2
Astellas Pharma US Inc $38.35 2
Kite Pharma, Inc. $33.46 1
Genentech USA, Inc. $30.09 2
ADC THERAPEUTICS AMERICA, INC. $26.33 1
TAIHO ONCOLOGY, INC. $26.30 1
Ipsen Biopharmaceuticals, Inc $23.88 1
Sumitomo Pharma America, Inc. $23.30 1
SERVIER PHARMACEUTICALS LLC $22.20 1
Dendreon Pharmaceuticals LLC $21.50 1
Exelixis Inc. $19.60 1
Karyopharm Therapeutics Inc. $18.89 1
Aveo Pharmaceuticals, Inc. $18.37 1
Iovance Biotherapeutics, Inc. $18.13 1
Corcept Therapeutics $17.82 1
Teleflex LLC $16.67 1
JAZZ PHARMACEUTICALS INC. $15.39 1

Page 4 of 4; records 151–188 of 188 matching records. This page contains 38 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

WENQING ZHANG

NPI 1720286594 · CMS profile ID 259562

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

INVERNESS, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 4; records 151–188 of 188 matching records. This page contains 38 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1720286594?year=2025&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
WENQING ZHANG, NPI 1720286594, CMS profile ID 259562. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–188 of 188 matching records. This page contains 38 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1720286594?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). WENQING ZHANG, NPI 1720286594, CMS profile ID 259562. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–188 of 188 matching records. This page contains 38 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1720286594?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
WENQING ZHANG, NPI 1720286594, CMS profile ID 259562, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–188 of 188 matching records. This page contains 38 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1720286594?year=2025&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

188 matching records · $5,219.55 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 188 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–188 of 188.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $15.1603/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200499459 CMS
Novartis Pharmaceuticals Corporation $0.9603/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200499461 CMS
Novartis Pharmaceuticals Corporation $22.3903/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200499457 CMS
SOBI, INC $26.6703/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240270573 CMS
Novartis Pharmaceuticals Corporation $27.9903/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200499455 CMS
BeiGene USA, Inc. $31.1802/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202882408 CMS
PFIZER INC. $25.6002/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229978191 CMS
Astellas Pharma US Inc $16.5102/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238745840 CMS
Kite Pharma, Inc. $33.4602/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212084263 CMS
AstraZeneca Pharmaceuticals LP $18.9802/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206278078 CMS
Bayer Healthcare Pharmaceuticals Inc. $25.0202/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225921984 CMS
Novartis Pharmaceuticals Corporation $99.7002/21/2025 Long term medical supply or device loan No dispute reported Delay: No
Change: NEW
06/30/2026 1200499443 CMS
Celgene Corporation $16.1502/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184692053 CMS
Celgene Corporation $4.3302/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184692055 CMS
Iovance Biotherapeutics, Inc. $18.1302/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251398333 CMS
E.R. Squibb & Sons, L.L.C. $26.7702/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184692023 CMS
BeiGene USA, Inc. $25.7002/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202882406 CMS
Stemline Therapeutics Inc. $18.2602/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244111359 CMS
PFIZER INC. $23.9502/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230064397 CMS
Eisai Inc. $18.7902/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244519122 CMS
Merck Sharp & Dohme LLC $15.9602/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238140346 CMS
PFIZER INC. $21.1201/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230090568 CMS
PUMA BIOTECHNOLOGY, INC. $19.0201/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251743770 CMS
E.R. Squibb & Sons, L.L.C. $16.1701/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184692015 CMS
Eisai Inc. $32.4501/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244519120 CMS
Merck Sharp & Dohme LLC $20.9201/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238097118 CMS
Novartis Pharmaceuticals Corporation $99.7001/23/2025 Long term medical supply or device loan No dispute reported Delay: No
Change: NEW
06/30/2026 1200499441 CMS
Lilly USA, LLC $26.8501/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1187059677 CMS
ARRAY BIOPHARMA INC $21.8101/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230029948 CMS
Daiichi Sankyo Inc. $20.0101/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197076295 CMS
Merck Sharp & Dohme LLC $18.3501/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238192050 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $39.8401/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251069786 CMS
ABBVIE INC. $22.8201/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204858430 CMS
EMD Serono, Inc. $20.4701/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236876419 CMS
E.R. Squibb & Sons, L.L.C. $20.1801/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184692009 CMS
ADC THERAPEUTICS AMERICA, INC. $26.3301/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246117044 CMS
Incyte Corporation $23.5401/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226008079 CMS
E.R. Squibb & Sons, L.L.C. $25.7801/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184692007 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $284.63 10
PY2020 $270.03 11
PY2021 $416.36 5
PY2022 $530.15 11
PY2023 $2,475.76 96
PY2024 $5,261.66 197
PY2025 $5,219.55 188

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $5,630.00 3
PY2020 Principal investigator $80,430.24 5
PY2019 Principal investigator $56,072.27 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $820.00 10/04/2024 Non-covered Recipient Entity
Illinois CancerCare PC
A PHASE I DOSE ESCALATION AND EXPANDED COHORT STUDY OF PF06821497 IN THE TREATMENT OF ADULT PATIENTS WITH RELAPSEDREFRACTORY SMALL CELL LUNG CANCER SCLC CASTRATION RESISTANT PROSTATE CANCER CRPC AND FOLLICULAR LYMPHOMA FL No dispute reported 06/30/2026 1130998633
Principal investigator 1 PFIZER INC. $810.00 07/26/2024 Non-covered Recipient Entity
Illinois CancerCare PC
A PHASE I DOSE ESCALATION AND EXPANDED COHORT STUDY OF PF06821497 IN THE TREATMENT OF ADULT PATIENTS WITH RELAPSEDREFRACTORY SMALL CELL LUNG CANCER SCLC CASTRATION RESISTANT PROSTATE CANCER CRPC AND FOLLICULAR LYMPHOMA FL No dispute reported 06/30/2026 1130991657
Principal investigator 1 PFIZER INC. $4,000.00 07/10/2024 Non-covered Recipient Entity
Illinois CancerCare PC
A PHASE I DOSE ESCALATION AND EXPANDED COHORT STUDY OF PF06821497 IN THE TREATMENT OF ADULT PATIENTS WITH RELAPSEDREFRACTORY SMALL CELL LUNG CANCER SCLC CASTRATION RESISTANT PROSTATE CANCER CRPC AND FOLLICULAR LYMPHOMA FL No dispute reported 06/30/2026 1130992204